# 2025 Year in Review - Part 2

Page: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2
Text version: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2.md
Podcast: [Eyewire News: The Podcast](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536)
Published: 2025-12-31T05:00:00+00:00
Episode link: https://traffic.megaphone.fm/BMCL3297955984.mp3
Audio file: https://traffic.megaphone.fm/BMCL3297955984.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/2025-year-in-review-part-2
Duration seconds: 525

## Resource

Highlights from the last 6 months of 2025 include advancements of emerging technologies in glaucoma, the first pharmacologic treatment for myopia in Europe, the expansion of labels for anti-VEGF treatments, and the release of the DEWS III report exploring the diagnosis and management of dry eye disease. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/2025-year-in-review-part-2/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.